InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Lee Chan Henry. Officer active across 2 companies, notably BeOne Medicines Ltd.. In total, 48 disclosures have been published. Breakdown: 0 buy · 22 sells. Total volume traded: €4.3m. History available since 15 June 2023. The latest transaction was disclosed on 11 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lee Chan Henry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations48 total
812 shares@ US$194.47American Depositary SharesSEC:0001980648-26-000024:0
1,058 shares@ US$213.32American Depositary SharesSEC:0001980648-26-000024:1
796 shares@ US$159.03American Depositary SharesSEC:0001980648-26-000024:2
2,666 shares@ US$360.00American Depositary SharesSEC:0001980648-26-000024:3
1,044 shares@ US$323.690.0010% mcap9.2% of flowAmerican Depositary SharesSEC:0001980648-26-000021:0
514 shares@ US$194.470.0003% mcap3.0% of flowAmerican Depositary SharesSEC:0001980648-26-000019:0
665 shares@ US$213.320.0004% mcap4.3% of flowAmerican Depositary SharesSEC:0001980648-26-000019:1
490 shares@ US$159.030.0002% mcap2.4% of flowAmerican Depositary SharesSEC:0001980648-26-000019:2
1,669 shares@ US$325.000.0016% mcap16.4% of flowAmerican Depositary SharesSEC:0001980648-26-000019:3
202 shares@ US$194.470.0001% mcap1.6% of flowAmerican Depositary SharesSEC:0001980648-26-000017:0
266 shares@ US$213.320.0002% mcap2.3% of flowAmerican Depositary SharesSEC:0001980648-26-000017:1
196 shares@ US$159.030.0001% mcap1.3% of flowAmerican Depositary SharesSEC:0001980648-26-000017:2
664 shares@ US$302.460.0006% mcap8.2% of flowAmerican Depositary SharesSEC:0001980648-26-000017:3
590 sharesAmerican Depositary SharesSEC:0001980648-26-000015:0
45,071 sharesOrdinary SharesSEC:0001980648-26-000014:0
428 sharesAmerican Depositary SharesSEC:0001980648-26-000014:1
711 sharesAmerican Depositary SharesSEC:0001980648-26-000013:0
160 sharesAmerican Depositary SharesSEC:0001980648-26-000013:1
133 shares@ US$213.320.0001% mcap15.2% of flowAmerican Depositary SharesSEC:0001980648-26-000012:1
98 shares@ US$159.030.0000% mcap8.4% of flowAmerican Depositary SharesSEC:0001980648-26-000012:2
332 shares@ US$310.720.0003% mcap55.3% of flowAmerican Depositary SharesSEC:0001980648-26-000012:3
101 shares@ US$194.470.0001% mcap50.0% of flowAmerican Depositary SharesSEC:0001980648-26-000012:0
101 shares@ US$194.475.6% of flowAmerican Depositary SharesSEC:0001980648-26-000010:0
133 shares@ US$213.328.0% of flowAmerican Depositary SharesSEC:0001980648-26-000010:1
98 shares@ US$159.034.4% of flowAmerican Depositary SharesSEC:0001980648-26-000010:2
25 of 48 declarations
About Lee Chan Henry
Lee Chan Henry is a declarant, associated with BeOne Medicines Ltd. and BeiGene, Ltd. as SVP, General Counsel. The 39 filings in total are covered by the 39 sampled filings, from 2023-06-20 to 2026-07-10, and show disposals totaling EUR 2718093, with no purchases reported.
